An international expert group appointed by the European Union Geriatric Medicine Society reviewed the evidence on how much dietary protein older adults need. They accounted for age-related changes in protein metabolism and for the effect of illness and inactivity. The group recommends 1.0 to 1.2 g of protein per kg of body weight per day for most people over 65, higher amounts for those who are active or unwell, alongside endurance and resistance exercise.
Protein guidelines have long given every adult the same number regardless of age: 0.8 grams per kilogram of body weight per day. That figure takes no account of what changes with age. Older people extract more of an ingested protein load in the gut and liver before it reaches muscle, and their muscle responds less to what does arrive. Illness adds further demand. A group convened by the European Union Geriatric Medicine Society reviewed the evidence and produced updated recommendations for people over 65.
This is a position paper from an appointed expert panel, not a trial. The EUGMS appointed an international study group of 13 members led by Jurgen Bauer and Yves Boirie, covering geriatric medicine, endocrinology, nutrition, exercise physiology, gastroenterology and renal medicine. The group first met in July 2012 and then worked by email, following a Delphi-like consensus process of structured discussion, evidence-based reasoning and iterative steps toward agreement. It reviewed protein needs in healthy older people and in disease, exercise alongside protein, protein source and timing, and functional outcomes.
The key recommendations are:
The group says protein quality, timing and amino acid supplementation may be worth considering, but evidence is not yet sufficient for specific recommendations.
The funding and conflict declarations should be read carefully. The EUGMS received a grant from Nestle Nutrition to fund this study group, which paid for its operational activities and its meeting. However, most named authors declare payments from nutrition companies: speaker honoraria, consultancies or research grants from Nestle, Nutricia, Abbott, Fresenius, Lactalis, Sanofi-Aventis, Pfizer, Novartis, Purina, Baxter and Shire appear across the author list. One author, P.S., declared no conflict of interest. Beyond funding, this is consensus expert opinion rather than a systematic review, with no pooled effect estimates and no formal evidence grading. The authors note that longer-term studies are needed and that relatively few studies of protein in older people have used physical function as an outcome.
These recommendations are written for and about people over 65, including frail, hospitalized and chronically ill older adults. The figures do not automatically extend to healthy or younger people, whose metabolism the paper explicitly contrasts with the older group's. It names a clear exception where more protein is the wrong answer: severe kidney disease without dialysis. It reports no trial result, so it is not evidence that any particular product changes outcomes. It is a panel's reading of the literature, produced with industry funding.
That depends on the specific medication and formula. A few, like blood thinners with CurQLife or blood pressure medication with MaxiNOs, are worth a direct conversation with your doctor first. Check each formula's own FAQ section for specifics, or ask your health coach.
No, and we'd rather be upfront about it. Bacopa, the plant in BacoZest, has published human studies, though they used other bacopa extracts. OptiNOs and MaxiNOs each have human studies sponsored by their maker, Laila Nutraceuticals, which haven't been published in a journal. CurQLife's research is still early, from lab and animal studies, and we label it that way.
It depends on what you're building your routine around. BacoZest is built around bacopa, which is studied for memory.* OptiNOs supports strength and muscular endurance alongside resistance training.* MaxiNOs was studied for healthy blood vessel function.* CurQLife's research is still at the lab stage. Your health coach can help you pick a starting point.
All four are built around plant extracts. OptiNOs was reported as well tolerated in its human study, and published bacopa studies reported no serious side effects. CurQLife's safety data so far comes from lab and animal testing. Check with your doctor first if you're pregnant, nursing, on medication, or managing a health condition.
Because the patented ingredients behind our four formulas went through dedicated research, and research costs real money. A generic curcumin or bacopa supplement hasn't been tested in the form you get from us. You're paying for an ingredient with research behind it, not just a label.
Generic ingredients often haven't been studied in the specific form you're buying. Our four core formulas use patented ingredients, and we show you the research behind each one, including where it's still early.
It depends on the formula. In its study, MaxiNOs blood vessel response was higher than placebo 2 to 3 hours after the first dose.* OptiNOs and bacopa were studied over 6 and 12 weeks of daily use, so give them time. CurQLife is meant to be taken daily.
Yes. BacoZest, OptiNOs, MaxiNOs, and CurQLife are built for different goals, and none of them contain stimulants. They haven't been studied together, so ask your health coach how to fit them into your routine.
